at-752
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 9, 2021 (NCT04722627)
Timeline
Indications
Studied for
Mechanism of action
- Dengue virusINHIBITOR
Dengue virus inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05366439 | Phase 1 | May 31, 2022 | Atea Pharmaceuticals, Inc. |
| NCT05466240 | Phase 2 | Apr 29, 2022 | Atea Pharmaceuticals, Inc. |
| NCT04722627 | Phase 1 | Mar 9, 2021 | Atea Pharmaceuticals, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Atea Pharmaceuticals, Inc. | For profit | 3 | 3 | 2 | 2021 |
1 organizations
Page 1 / 1